1. Home
  2. Analysis
  3. Ventavis
  4. Urticaria

Ventavis and Urticaria - a phase IV clinical study of FDA data

Summary:

Urticaria is reported as a side effect among people who take Ventavis (iloprost), especially for people who are male, 50-59 old, have been taking the drug for 1 - 2 years also take Tracleer, and have Primary pulmonary hypertension.

The phase IV clinical study analyzes which people have Urticaria when taking Ventavis. It is created by eHealthMe based on reports of 11,968 people who have side effects when taking Ventavis from the FDA, and is updated regularly.

What is Ventavis?

Ventavis has active ingredients of iloprost. eHealthMe is studying from 11,982 Ventavis users. Check the latest studies of Ventavis.

What is Urticaria?

Urticaria (rash of round, red welts on the skin that itch intensely) is found to be associated with 2,624 drugs and 2,952 conditions by eHealthMe. Check the latest studies of Urticaria.

On Jul, 07, 2026

11,968 people reported to have side effects when taking Ventavis.
Among them, 17 people (0.14%) have Urticaria.

Could Ventavis cause Urticaria?

Among these 17 people:

How long have people been on Ventavis when they have Urticaria? *

  • < 1 month: 25 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 50 %
  • 2 - 5 years: 25 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

What is the gender of people who have Urticaria when taking Ventavis? *

  • female: 47.06 %
  • male: 52.94 %

What is the age of people who have Urticaria when taking Ventavis? *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 20.0 %
  • 20-29: 6.67 %
  • 30-39: 13.33 %
  • 40-49: 0.0 %
  • 50-59: 46.67 %
  • 60+: 13.33 %

What are other drugs people take besides Ventavis? *

  1. Tracleer: 8 people, 47.06%
  2. Adcirca: 6 people, 35.29%
  3. Remodulin: 4 people, 23.53%
  4. Zyrtec: 3 people, 17.65%
  5. Letairis: 3 people, 17.65%
  6. Coumadin: 3 people, 17.65%
  7. Spironolactone: 3 people, 17.65%
  8. Revatio: 3 people, 17.65%
  9. Flolan: 3 people, 17.65%
  10. Orenitram: 3 people, 17.65%

What are other side effects people have besides Urticaria? *

  1. Rashes (redness): 7 people, 41.18%
  2. Oedema (fluid collection in tissue): 5 people, 29.41%
  3. Swelling: 5 people, 29.41%
  4. Nausea (feeling of having an urge to vomit): 4 people, 23.53%
  5. Dyspnea (difficult or laboured breathing): 4 people, 23.53%
  6. Itching: 4 people, 23.53%
  7. Heart Palpitations (feelings or sensations that your heart is pounding or racing): 3 people, 17.65%
  8. Skin Blushing/flushing (a sudden reddening of the face, neck): 3 people, 17.65%
  9. Chest Pain: 3 people, 17.65%
  10. Dizziness: 3 people, 17.65%

What are the existing conditions these people have? *

  1. Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 15 people, 88.24%
  2. Pulmonary Hypertension (increase in blood pressure in the lung artery): 2 people, 11.76%
  3. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 1 person, 5.88%

* Approximation only. Some reports may have incomplete information.

Do you take Ventavis and have Urticaria?

- Check whether Urticaria is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Ventavis:

Urticaria treatments and more:

How severe was Urticaria and when was it recovered:

Expand to all the drugs that have ingredients of iloprost:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Ventavis:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Urticaria:

Browse all the conditions that are associated with Urticaria:

Related publications that referenced our studies

How the study uses the data?

The study uses data from the FDA. It is based on iloprost (the active ingredients of Ventavis) and Ventavis (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.